65LAB

65LAB is a translational engine and venture studio dedicated to identifying and accelerating early-stage therapeutic projects from leading Belgian academic institutions. Established as a collaborative initiative between Evotec and V-Bio Ventures, the organization bridges the gap between academic research and the creation of investment-ready biotech companies. 65LAB provides academic researchers with access to Evotec's industrial-scale drug discovery and development platforms, alongside financial support and venture building expertise. The partnership involves several prominent Belgian universities, focusing on transforming high-potential science into novel medicines across a broad range of therapeutic areas.